nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—Citalopram—alcohol dependence	0.169	0.324	CbGbCtD
Palonosetron—CYP2D6—Citalopram—alcohol dependence	0.139	0.267	CbGbCtD
Palonosetron—CYP3A4—Disulfiram—alcohol dependence	0.124	0.238	CbGbCtD
Palonosetron—CYP3A4—Citalopram—alcohol dependence	0.0885	0.17	CbGbCtD
Palonosetron—Vein distended—Citalopram—alcohol dependence	0.0254	0.0803	CcSEcCtD
Palonosetron—Vasodilatation—Citalopram—alcohol dependence	0.0133	0.042	CcSEcCtD
Palonosetron—HTR3A—Ligand-gated ion channel transport—GABRB1—alcohol dependence	0.00936	0.0643	CbGpPWpGaD
Palonosetron—Motion sickness—Citalopram—alcohol dependence	0.00934	0.0295	CcSEcCtD
Palonosetron—Joint stiffness—Naltrexone—alcohol dependence	0.00801	0.0253	CcSEcCtD
Palonosetron—HTR3A—Ligand-gated ion channel transport—GABRA2—alcohol dependence	0.00796	0.0547	CbGpPWpGaD
Palonosetron—Dermatitis atopic—Disulfiram—alcohol dependence	0.00701	0.0221	CcSEcCtD
Palonosetron—Hypersomnia—Citalopram—alcohol dependence	0.00587	0.0185	CcSEcCtD
Palonosetron—Induration—Naltrexone—alcohol dependence	0.00541	0.0171	CcSEcCtD
Palonosetron—Joint stiffness—Citalopram—alcohol dependence	0.00508	0.016	CcSEcCtD
Palonosetron—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00491	0.0337	CbGpPWpGaD
Palonosetron—CYP2D6—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00481	0.033	CbGpPWpGaD
Palonosetron—Eye swelling—Citalopram—alcohol dependence	0.0047	0.0148	CcSEcCtD
Palonosetron—Dizziness postural—Citalopram—alcohol dependence	0.00439	0.0138	CcSEcCtD
Palonosetron—Supraventricular extrasystoles—Citalopram—alcohol dependence	0.00411	0.013	CcSEcCtD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00408	0.028	CbGpPWpGaD
Palonosetron—Platelet count decreased—Naltrexone—alcohol dependence	0.00407	0.0128	CcSEcCtD
Palonosetron—CYP2D6—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00399	0.0274	CbGpPWpGaD
Palonosetron—Sinus tachycardia—Citalopram—alcohol dependence	0.00381	0.012	CcSEcCtD
Palonosetron—Laryngospasm—Acamprosate—alcohol dependence	0.00342	0.0108	CcSEcCtD
Palonosetron—CYP2D6—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00339	0.0233	CbGpPWpGaD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00338	0.0232	CbGpPWpGaD
Palonosetron—Amblyopia—Acamprosate—alcohol dependence	0.00331	0.0105	CcSEcCtD
Palonosetron—HTR3A—nerve—alcohol dependence	0.00327	0.193	CbGeAlD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00315	0.0216	CbGpPWpGaD
Palonosetron—Sinus bradycardia—Citalopram—alcohol dependence	0.00313	0.00986	CcSEcCtD
Palonosetron—CYP2D6—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00288	0.0198	CbGpPWpGaD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00287	0.0197	CbGpPWpGaD
Palonosetron—Hyperbilirubinaemia—Acamprosate—alcohol dependence	0.00281	0.00887	CcSEcCtD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00261	0.0179	CbGpPWpGaD
Palonosetron—Platelet count decreased—Citalopram—alcohol dependence	0.00258	0.00813	CcSEcCtD
Palonosetron—Hepatic enzyme increased—Naltrexone—alcohol dependence	0.00256	0.00807	CcSEcCtD
Palonosetron—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00253	0.0174	CbGpPWpGaD
Palonosetron—Salivary hypersecretion—Acamprosate—alcohol dependence	0.00248	0.00784	CcSEcCtD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00244	0.0168	CbGpPWpGaD
Palonosetron—Injection site reaction—Naltrexone—alcohol dependence	0.0024	0.00759	CcSEcCtD
Palonosetron—Electrocardiogram QT prolonged—Citalopram—alcohol dependence	0.00239	0.00754	CcSEcCtD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00222	0.0152	CbGpPWpGaD
Palonosetron—Cyanosis—Citalopram—alcohol dependence	0.00217	0.00683	CcSEcCtD
Palonosetron—CYP1A2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00215	0.0148	CbGpPWpGaD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00214	0.0147	CbGpPWpGaD
Palonosetron—Euphoric mood—Naltrexone—alcohol dependence	0.00208	0.00656	CcSEcCtD
Palonosetron—Dermatitis atopic—Citalopram—alcohol dependence	0.00207	0.00654	CcSEcCtD
Palonosetron—CYP1A2—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00204	0.014	CbGpPWpGaD
Palonosetron—HTR3A—Ion channel transport—GABRB1—alcohol dependence	0.00203	0.014	CbGpPWpGaD
Palonosetron—Amblyopia—Citalopram—alcohol dependence	0.00199	0.00626	CcSEcCtD
Palonosetron—Feeling hot—Citalopram—alcohol dependence	0.00195	0.00616	CcSEcCtD
Palonosetron—CYP2D6—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00192	0.0132	CbGpPWpGaD
Palonosetron—Myocardial ischaemia—Citalopram—alcohol dependence	0.00191	0.00602	CcSEcCtD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00188	0.0129	CbGpPWpGaD
Palonosetron—Hot flush—Naltrexone—alcohol dependence	0.00188	0.00592	CcSEcCtD
Palonosetron—Menopausal symptoms—Naltrexone—alcohol dependence	0.00186	0.00587	CcSEcCtD
Palonosetron—Pallor—Citalopram—alcohol dependence	0.00185	0.00584	CcSEcCtD
Palonosetron—Extrasystoles—Citalopram—alcohol dependence	0.00182	0.00575	CcSEcCtD
Palonosetron—Eye irritation—Citalopram—alcohol dependence	0.0018	0.00567	CcSEcCtD
Palonosetron—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00178	0.0122	CbGpPWpGaD
Palonosetron—Pain in extremity—Naltrexone—alcohol dependence	0.00176	0.00554	CcSEcCtD
Palonosetron—HTR3A—Ion channel transport—GABRA2—alcohol dependence	0.00173	0.0119	CbGpPWpGaD
Palonosetron—Hyperbilirubinaemia—Citalopram—alcohol dependence	0.00169	0.00532	CcSEcCtD
Palonosetron—Hypocalcaemia—Citalopram—alcohol dependence	0.00167	0.00528	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00167	0.00527	CcSEcCtD
Palonosetron—Paraesthesia—Disulfiram—alcohol dependence	0.00166	0.00525	CcSEcCtD
Palonosetron—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00166	0.0114	CbGpPWpGaD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00165	0.0114	CbGpPWpGaD
Palonosetron—Somnolence—Disulfiram—alcohol dependence	0.00165	0.0052	CcSEcCtD
Palonosetron—Gastritis—Acamprosate—alcohol dependence	0.00164	0.00518	CcSEcCtD
Palonosetron—Dyskinesia—Citalopram—alcohol dependence	0.00163	0.00515	CcSEcCtD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00163	0.0112	CbGpPWpGaD
Palonosetron—Hepatic enzyme increased—Citalopram—alcohol dependence	0.00162	0.00511	CcSEcCtD
Palonosetron—Abdominal distension—Acamprosate—alcohol dependence	0.00161	0.0051	CcSEcCtD
Palonosetron—Abdominal pain upper—Naltrexone—alcohol dependence	0.0016	0.00506	CcSEcCtD
Palonosetron—Fatigue—Disulfiram—alcohol dependence	0.0016	0.00504	CcSEcCtD
Palonosetron—Pain—Disulfiram—alcohol dependence	0.00158	0.005	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00158	0.00499	CcSEcCtD
Palonosetron—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00157	0.0108	CbGpPWpGaD
Palonosetron—Hiccups—Citalopram—alcohol dependence	0.00153	0.00484	CcSEcCtD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00151	0.0104	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.00149	0.0102	CbGpPWpGaD
Palonosetron—Salivary hypersecretion—Citalopram—alcohol dependence	0.00149	0.0047	CcSEcCtD
Palonosetron—Influenza like illness—Citalopram—alcohol dependence	0.00149	0.0047	CcSEcCtD
Palonosetron—Fluid retention—Citalopram—alcohol dependence	0.00146	0.00459	CcSEcCtD
Palonosetron—Hyperglycaemia—Acamprosate—alcohol dependence	0.00145	0.00457	CcSEcCtD
Palonosetron—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00142	0.00978	CbGpPWpGaD
Palonosetron—HTR3A—brainstem—alcohol dependence	0.0014	0.083	CbGeAlD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00135	0.00931	CbGpPWpGaD
Palonosetron—HTR3A—forebrain—alcohol dependence	0.00135	0.0801	CbGeAlD
Palonosetron—Epistaxis—Acamprosate—alcohol dependence	0.00135	0.00426	CcSEcCtD
Palonosetron—Asthenia—Disulfiram—alcohol dependence	0.00133	0.00419	CcSEcCtD
Palonosetron—Euphoric mood—Citalopram—alcohol dependence	0.00132	0.00416	CcSEcCtD
Palonosetron—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00128	0.00404	CcSEcCtD
Palonosetron—Epistaxis—Naltrexone—alcohol dependence	0.00128	0.00403	CcSEcCtD
Palonosetron—Sinusitis—Naltrexone—alcohol dependence	0.00127	0.00401	CcSEcCtD
Palonosetron—Dizziness—Disulfiram—alcohol dependence	0.00122	0.00386	CcSEcCtD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00121	0.00828	CbGpPWpGaD
Palonosetron—Tinnitus—Acamprosate—alcohol dependence	0.0012	0.00378	CcSEcCtD
Palonosetron—Connective tissue disorder—Naltrexone—alcohol dependence	0.00119	0.00377	CcSEcCtD
Palonosetron—CYP2D6—Xenobiotics—CYP2E1—alcohol dependence	0.00119	0.00818	CbGpPWpGaD
Palonosetron—Hot flush—Citalopram—alcohol dependence	0.00119	0.00375	CcSEcCtD
Palonosetron—Menopausal symptoms—Citalopram—alcohol dependence	0.00118	0.00372	CcSEcCtD
Palonosetron—Rash—Disulfiram—alcohol dependence	0.00117	0.00369	CcSEcCtD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00116	0.008	CbGpPWpGaD
Palonosetron—Headache—Disulfiram—alcohol dependence	0.00116	0.00366	CcSEcCtD
Palonosetron—Immune system disorder—Acamprosate—alcohol dependence	0.00116	0.00366	CcSEcCtD
Palonosetron—Chills—Acamprosate—alcohol dependence	0.00115	0.00364	CcSEcCtD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00115	0.00788	CbGpPWpGaD
Palonosetron—CYP2D6—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00115	0.00787	CbGpPWpGaD
Palonosetron—Eye disorder—Naltrexone—alcohol dependence	0.00114	0.00358	CcSEcCtD
Palonosetron—Alopecia—Acamprosate—alcohol dependence	0.00113	0.00358	CcSEcCtD
Palonosetron—Tinnitus—Naltrexone—alcohol dependence	0.00113	0.00357	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.00113	0.00776	CbGpPWpGaD
Palonosetron—Cardiac disorder—Naltrexone—alcohol dependence	0.00113	0.00356	CcSEcCtD
Palonosetron—Mental disorder—Acamprosate—alcohol dependence	0.00112	0.00355	CcSEcCtD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00112	0.00771	CbGpPWpGaD
Palonosetron—Malnutrition—Acamprosate—alcohol dependence	0.00112	0.00353	CcSEcCtD
Palonosetron—Pain in extremity—Citalopram—alcohol dependence	0.00111	0.00351	CcSEcCtD
Palonosetron—Angiopathy—Naltrexone—alcohol dependence	0.0011	0.00348	CcSEcCtD
Palonosetron—Flatulence—Acamprosate—alcohol dependence	0.0011	0.00348	CcSEcCtD
Palonosetron—Immune system disorder—Naltrexone—alcohol dependence	0.0011	0.00346	CcSEcCtD
Palonosetron—Mediastinal disorder—Naltrexone—alcohol dependence	0.00109	0.00346	CcSEcCtD
Palonosetron—Dysgeusia—Acamprosate—alcohol dependence	0.00109	0.00345	CcSEcCtD
Palonosetron—Chills—Naltrexone—alcohol dependence	0.00109	0.00344	CcSEcCtD
Palonosetron—Alopecia—Naltrexone—alcohol dependence	0.00107	0.00339	CcSEcCtD
Palonosetron—Mental disorder—Naltrexone—alcohol dependence	0.00106	0.00336	CcSEcCtD
Palonosetron—Urinary retention—Citalopram—alcohol dependence	0.00106	0.00334	CcSEcCtD
Palonosetron—Malnutrition—Naltrexone—alcohol dependence	0.00106	0.00334	CcSEcCtD
Palonosetron—Flatulence—Naltrexone—alcohol dependence	0.00104	0.00329	CcSEcCtD
Palonosetron—Dysgeusia—Naltrexone—alcohol dependence	0.00104	0.00327	CcSEcCtD
Palonosetron—Anaemia—Acamprosate—alcohol dependence	0.00103	0.00326	CcSEcCtD
Palonosetron—Abdominal pain upper—Citalopram—alcohol dependence	0.00102	0.00321	CcSEcCtD
Palonosetron—Hypokalaemia—Citalopram—alcohol dependence	0.00101	0.0032	CcSEcCtD
Palonosetron—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.00101	0.00693	CbGpPWpGaD
Palonosetron—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.001	0.00316	CcSEcCtD
Palonosetron—Gastritis—Citalopram—alcohol dependence	0.000985	0.00311	CcSEcCtD
Palonosetron—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00097	0.00666	CbGpPWpGaD
Palonosetron—Convulsion—Acamprosate—alcohol dependence	0.000968	0.00306	CcSEcCtD
Palonosetron—Abdominal distension—Citalopram—alcohol dependence	0.000968	0.00306	CcSEcCtD
Palonosetron—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000965	0.00663	CbGpPWpGaD
Palonosetron—Hypertension—Acamprosate—alcohol dependence	0.000965	0.00305	CcSEcCtD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000955	0.00656	CbGpPWpGaD
Palonosetron—Arthralgia—Acamprosate—alcohol dependence	0.000952	0.003	CcSEcCtD
Palonosetron—Myalgia—Acamprosate—alcohol dependence	0.000952	0.003	CcSEcCtD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000951	0.00653	CbGpPWpGaD
Palonosetron—HTR3A—digestive system—alcohol dependence	0.000951	0.0562	CbGeAlD
Palonosetron—Anxiety—Acamprosate—alcohol dependence	0.000948	0.00299	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000945	0.00298	CcSEcCtD
Palonosetron—Discomfort—Acamprosate—alcohol dependence	0.00094	0.00297	CcSEcCtD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000931	0.00639	CbGpPWpGaD
Palonosetron—Dry mouth—Acamprosate—alcohol dependence	0.000931	0.00294	CcSEcCtD
Palonosetron—Convulsion—Naltrexone—alcohol dependence	0.000916	0.00289	CcSEcCtD
Palonosetron—Hypertension—Naltrexone—alcohol dependence	0.000913	0.00288	CcSEcCtD
Palonosetron—Anaphylactic shock—Acamprosate—alcohol dependence	0.000912	0.00288	CcSEcCtD
Palonosetron—Infection—Acamprosate—alcohol dependence	0.000906	0.00286	CcSEcCtD
Palonosetron—HTR3A—blood—alcohol dependence	0.000906	0.0535	CbGeAlD
Palonosetron—Myalgia—Naltrexone—alcohol dependence	0.0009	0.00284	CcSEcCtD
Palonosetron—Arthralgia—Naltrexone—alcohol dependence	0.0009	0.00284	CcSEcCtD
Palonosetron—Shock—Acamprosate—alcohol dependence	0.000898	0.00283	CcSEcCtD
Palonosetron—Anxiety—Naltrexone—alcohol dependence	0.000897	0.00283	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000894	0.00282	CcSEcCtD
Palonosetron—Tachycardia—Acamprosate—alcohol dependence	0.00089	0.00281	CcSEcCtD
Palonosetron—Discomfort—Naltrexone—alcohol dependence	0.00089	0.00281	CcSEcCtD
Palonosetron—Skin disorder—Acamprosate—alcohol dependence	0.000886	0.0028	CcSEcCtD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000886	0.00608	CbGpPWpGaD
Palonosetron—Dry mouth—Naltrexone—alcohol dependence	0.000881	0.00278	CcSEcCtD
Palonosetron—Anorexia—Acamprosate—alcohol dependence	0.00087	0.00274	CcSEcCtD
Palonosetron—Hyperglycaemia—Citalopram—alcohol dependence	0.000867	0.00274	CcSEcCtD
Palonosetron—Anaphylactic shock—Naltrexone—alcohol dependence	0.000863	0.00272	CcSEcCtD
Palonosetron—Infection—Naltrexone—alcohol dependence	0.000857	0.00271	CcSEcCtD
Palonosetron—Hypotension—Acamprosate—alcohol dependence	0.000852	0.00269	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000851	0.00584	CbGpPWpGaD
Palonosetron—Shock—Naltrexone—alcohol dependence	0.000849	0.00268	CcSEcCtD
Palonosetron—Nervous system disorder—Naltrexone—alcohol dependence	0.000846	0.00267	CcSEcCtD
Palonosetron—Tachycardia—Naltrexone—alcohol dependence	0.000842	0.00266	CcSEcCtD
Palonosetron—Skin disorder—Naltrexone—alcohol dependence	0.000838	0.00265	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000833	0.00572	CbGpPWpGaD
Palonosetron—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000831	0.00262	CcSEcCtD
Palonosetron—Insomnia—Acamprosate—alcohol dependence	0.000825	0.0026	CcSEcCtD
Palonosetron—Anorexia—Naltrexone—alcohol dependence	0.000823	0.0026	CcSEcCtD
Palonosetron—Paraesthesia—Acamprosate—alcohol dependence	0.000819	0.00259	CcSEcCtD
Palonosetron—Dyspnoea—Acamprosate—alcohol dependence	0.000813	0.00257	CcSEcCtD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000812	0.00557	CbGpPWpGaD
Palonosetron—Somnolence—Acamprosate—alcohol dependence	0.000811	0.00256	CcSEcCtD
Palonosetron—Hepatobiliary disease—Citalopram—alcohol dependence	0.000811	0.00256	CcSEcCtD
Palonosetron—Epistaxis—Citalopram—alcohol dependence	0.000809	0.00255	CcSEcCtD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000809	0.00555	CbGpPWpGaD
Palonosetron—Sinusitis—Citalopram—alcohol dependence	0.000804	0.00254	CcSEcCtD
Palonosetron—Dyspepsia—Acamprosate—alcohol dependence	0.000803	0.00253	CcSEcCtD
Palonosetron—Decreased appetite—Acamprosate—alcohol dependence	0.000793	0.0025	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000788	0.00249	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000786	0.00248	CcSEcCtD
Palonosetron—Bradycardia—Citalopram—alcohol dependence	0.000784	0.00247	CcSEcCtD
Palonosetron—Insomnia—Naltrexone—alcohol dependence	0.000781	0.00246	CcSEcCtD
Palonosetron—Constipation—Acamprosate—alcohol dependence	0.00078	0.00246	CcSEcCtD
Palonosetron—Pain—Acamprosate—alcohol dependence	0.00078	0.00246	CcSEcCtD
Palonosetron—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000779	0.00535	CbGpPWpGaD
Palonosetron—Paraesthesia—Naltrexone—alcohol dependence	0.000775	0.00245	CcSEcCtD
Palonosetron—Dyspnoea—Naltrexone—alcohol dependence	0.000769	0.00243	CcSEcCtD
Palonosetron—Somnolence—Naltrexone—alcohol dependence	0.000767	0.00242	CcSEcCtD
Palonosetron—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.000762	0.00524	CbGpPWpGaD
Palonosetron—Urinary tract disorder—Citalopram—alcohol dependence	0.00076	0.0024	CcSEcCtD
Palonosetron—Connective tissue disorder—Citalopram—alcohol dependence	0.000756	0.00239	CcSEcCtD
Palonosetron—Urethral disorder—Citalopram—alcohol dependence	0.000755	0.00238	CcSEcCtD
Palonosetron—Decreased appetite—Naltrexone—alcohol dependence	0.00075	0.00237	CcSEcCtD
Palonosetron—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000749	0.00514	CbGpPWpGaD
Palonosetron—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000746	0.00235	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000745	0.00235	CcSEcCtD
Palonosetron—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000745	0.00512	CbGpPWpGaD
Palonosetron—Fatigue—Naltrexone—alcohol dependence	0.000744	0.00235	CcSEcCtD
Palonosetron—Pain—Naltrexone—alcohol dependence	0.000738	0.00233	CcSEcCtD
Palonosetron—Constipation—Naltrexone—alcohol dependence	0.000738	0.00233	CcSEcCtD
Palonosetron—HTR3A—nervous system—alcohol dependence	0.000735	0.0435	CbGeAlD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000734	0.00504	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000728	0.005	CbGpPWpGaD
Palonosetron—Abdominal pain—Acamprosate—alcohol dependence	0.000721	0.00228	CcSEcCtD
Palonosetron—Body temperature increased—Acamprosate—alcohol dependence	0.000721	0.00228	CcSEcCtD
Palonosetron—CYP2D6—Biological oxidations—ADH6—alcohol dependence	0.00072	0.00494	CbGpPWpGaD
Palonosetron—Eye disorder—Citalopram—alcohol dependence	0.000719	0.00227	CcSEcCtD
Palonosetron—Tinnitus—Citalopram—alcohol dependence	0.000718	0.00227	CcSEcCtD
Palonosetron—Cardiac disorder—Citalopram—alcohol dependence	0.000714	0.00225	CcSEcCtD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000712	0.00489	CbGpPWpGaD
Palonosetron—HTR3A—central nervous system—alcohol dependence	0.000708	0.0418	CbGeAlD
Palonosetron—HTR3A—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000707	0.00486	CbGpPWpGaD
Palonosetron—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000706	0.00223	CcSEcCtD
Palonosetron—Angiopathy—Citalopram—alcohol dependence	0.000698	0.0022	CcSEcCtD
Palonosetron—Immune system disorder—Citalopram—alcohol dependence	0.000695	0.00219	CcSEcCtD
Palonosetron—Mediastinal disorder—Citalopram—alcohol dependence	0.000694	0.00219	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000693	0.00476	CbGpPWpGaD
Palonosetron—Chills—Citalopram—alcohol dependence	0.000691	0.00218	CcSEcCtD
Palonosetron—Arrhythmia—Citalopram—alcohol dependence	0.000688	0.00217	CcSEcCtD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000688	0.00472	CbGpPWpGaD
Palonosetron—Abdominal pain—Naltrexone—alcohol dependence	0.000682	0.00215	CcSEcCtD
Palonosetron—Body temperature increased—Naltrexone—alcohol dependence	0.000682	0.00215	CcSEcCtD
Palonosetron—Alopecia—Citalopram—alcohol dependence	0.00068	0.00215	CcSEcCtD
Palonosetron—Mental disorder—Citalopram—alcohol dependence	0.000674	0.00213	CcSEcCtD
Palonosetron—Hypersensitivity—Acamprosate—alcohol dependence	0.000672	0.00212	CcSEcCtD
Palonosetron—Erythema—Citalopram—alcohol dependence	0.00067	0.00211	CcSEcCtD
Palonosetron—Malnutrition—Citalopram—alcohol dependence	0.00067	0.00211	CcSEcCtD
Palonosetron—Flatulence—Citalopram—alcohol dependence	0.00066	0.00208	CcSEcCtD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00066	0.00453	CbGpPWpGaD
Palonosetron—Dysgeusia—Citalopram—alcohol dependence	0.000656	0.00207	CcSEcCtD
Palonosetron—Asthenia—Acamprosate—alcohol dependence	0.000655	0.00207	CcSEcCtD
Palonosetron—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000648	0.00445	CbGpPWpGaD
Palonosetron—Pruritus—Acamprosate—alcohol dependence	0.000645	0.00204	CcSEcCtD
Palonosetron—Hypersensitivity—Naltrexone—alcohol dependence	0.000636	0.00201	CcSEcCtD
Palonosetron—Diarrhoea—Acamprosate—alcohol dependence	0.000624	0.00197	CcSEcCtD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000624	0.00429	CbGpPWpGaD
Palonosetron—Anaemia—Citalopram—alcohol dependence	0.000619	0.00195	CcSEcCtD
Palonosetron—Asthenia—Naltrexone—alcohol dependence	0.000619	0.00195	CcSEcCtD
Palonosetron—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000617	0.00424	CbGpPWpGaD
Palonosetron—Pruritus—Naltrexone—alcohol dependence	0.000611	0.00193	CcSEcCtD
Palonosetron—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.00061	0.00419	CbGpPWpGaD
Palonosetron—Dizziness—Acamprosate—alcohol dependence	0.000603	0.0019	CcSEcCtD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000603	0.00414	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000601	0.00413	CbGpPWpGaD
Palonosetron—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.000599	0.00411	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.000596	0.0041	CbGpPWpGaD
Palonosetron—Diarrhoea—Naltrexone—alcohol dependence	0.000591	0.00186	CcSEcCtD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00059	0.00405	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000588	0.00404	CbGpPWpGaD
Palonosetron—Convulsion—Citalopram—alcohol dependence	0.000581	0.00183	CcSEcCtD
Palonosetron—Vomiting—Acamprosate—alcohol dependence	0.00058	0.00183	CcSEcCtD
Palonosetron—Hypertension—Citalopram—alcohol dependence	0.000579	0.00183	CcSEcCtD
Palonosetron—Rash—Acamprosate—alcohol dependence	0.000575	0.00182	CcSEcCtD
Palonosetron—Dermatitis—Acamprosate—alcohol dependence	0.000575	0.00181	CcSEcCtD
Palonosetron—Headache—Acamprosate—alcohol dependence	0.000571	0.0018	CcSEcCtD
Palonosetron—Dizziness—Naltrexone—alcohol dependence	0.000571	0.0018	CcSEcCtD
Palonosetron—Myalgia—Citalopram—alcohol dependence	0.00057	0.0018	CcSEcCtD
Palonosetron—Arthralgia—Citalopram—alcohol dependence	0.00057	0.0018	CcSEcCtD
Palonosetron—Anxiety—Citalopram—alcohol dependence	0.000569	0.00179	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000567	0.00179	CcSEcCtD
Palonosetron—Discomfort—Citalopram—alcohol dependence	0.000564	0.00178	CcSEcCtD
Palonosetron—HTR3A—brain—alcohol dependence	0.000562	0.0332	CbGeAlD
Palonosetron—Dry mouth—Citalopram—alcohol dependence	0.000558	0.00176	CcSEcCtD
Palonosetron—Vomiting—Naltrexone—alcohol dependence	0.000549	0.00173	CcSEcCtD
Palonosetron—Anaphylactic shock—Citalopram—alcohol dependence	0.000547	0.00173	CcSEcCtD
Palonosetron—Rash—Naltrexone—alcohol dependence	0.000544	0.00172	CcSEcCtD
Palonosetron—Dermatitis—Naltrexone—alcohol dependence	0.000544	0.00172	CcSEcCtD
Palonosetron—Infection—Citalopram—alcohol dependence	0.000543	0.00171	CcSEcCtD
Palonosetron—Nausea—Acamprosate—alcohol dependence	0.000542	0.00171	CcSEcCtD
Palonosetron—Headache—Naltrexone—alcohol dependence	0.000541	0.00171	CcSEcCtD
Palonosetron—Shock—Citalopram—alcohol dependence	0.000538	0.0017	CcSEcCtD
Palonosetron—Nervous system disorder—Citalopram—alcohol dependence	0.000536	0.00169	CcSEcCtD
Palonosetron—Tachycardia—Citalopram—alcohol dependence	0.000534	0.00168	CcSEcCtD
Palonosetron—Skin disorder—Citalopram—alcohol dependence	0.000531	0.00168	CcSEcCtD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000531	0.00364	CbGpPWpGaD
Palonosetron—Anorexia—Citalopram—alcohol dependence	0.000521	0.00165	CcSEcCtD
Palonosetron—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000518	0.00356	CbGpPWpGaD
Palonosetron—CYP2D6—brainstem—alcohol dependence	0.000516	0.0305	CbGeAlD
Palonosetron—Nausea—Naltrexone—alcohol dependence	0.000513	0.00162	CcSEcCtD
Palonosetron—Hypotension—Citalopram—alcohol dependence	0.000511	0.00161	CcSEcCtD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000509	0.0035	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.000507	0.00348	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.000505	0.00347	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000501	0.00344	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.0005	0.00344	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.0005	0.00343	CbGpPWpGaD
Palonosetron—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000498	0.00157	CcSEcCtD
Palonosetron—CYP2D6—forebrain—alcohol dependence	0.000498	0.0294	CbGeAlD
Palonosetron—Insomnia—Citalopram—alcohol dependence	0.000495	0.00156	CcSEcCtD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000495	0.0034	CbGpPWpGaD
Palonosetron—Paraesthesia—Citalopram—alcohol dependence	0.000491	0.00155	CcSEcCtD
Palonosetron—CYP1A2—digestive system—alcohol dependence	0.000491	0.029	CbGeAlD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000488	0.00335	CbGpPWpGaD
Palonosetron—Dyspnoea—Citalopram—alcohol dependence	0.000488	0.00154	CcSEcCtD
Palonosetron—Somnolence—Citalopram—alcohol dependence	0.000486	0.00153	CcSEcCtD
Palonosetron—Dyspepsia—Citalopram—alcohol dependence	0.000481	0.00152	CcSEcCtD
Palonosetron—Decreased appetite—Citalopram—alcohol dependence	0.000475	0.0015	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000472	0.00149	CcSEcCtD
Palonosetron—Fatigue—Citalopram—alcohol dependence	0.000471	0.00149	CcSEcCtD
Palonosetron—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000471	0.00323	CbGpPWpGaD
Palonosetron—Pain—Citalopram—alcohol dependence	0.000468	0.00148	CcSEcCtD
Palonosetron—Constipation—Citalopram—alcohol dependence	0.000468	0.00148	CcSEcCtD
Palonosetron—CYP1A2—blood—alcohol dependence	0.000467	0.0276	CbGeAlD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000465	0.0032	CbGpPWpGaD
Palonosetron—Gastrointestinal pain—Citalopram—alcohol dependence	0.000447	0.00141	CcSEcCtD
Palonosetron—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000445	0.00306	CbGpPWpGaD
Palonosetron—Abdominal pain—Citalopram—alcohol dependence	0.000432	0.00136	CcSEcCtD
Palonosetron—Body temperature increased—Citalopram—alcohol dependence	0.000432	0.00136	CcSEcCtD
Palonosetron—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.000431	0.00296	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.00043	0.00295	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000425	0.00292	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000419	0.00288	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000413	0.00284	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000413	0.00284	CbGpPWpGaD
Palonosetron—CYP1A2—endocrine gland—alcohol dependence	0.000405	0.024	CbGeAlD
Palonosetron—Hypersensitivity—Citalopram—alcohol dependence	0.000403	0.00127	CcSEcCtD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000401	0.00275	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.0004	0.00275	CbGpPWpGaD
Palonosetron—Asthenia—Citalopram—alcohol dependence	0.000392	0.00124	CcSEcCtD
Palonosetron—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.00039	0.00268	CbGpPWpGaD
Palonosetron—Pruritus—Citalopram—alcohol dependence	0.000387	0.00122	CcSEcCtD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000386	0.00265	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000378	0.0026	CbGpPWpGaD
Palonosetron—Diarrhoea—Citalopram—alcohol dependence	0.000374	0.00118	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000367	0.00252	CbGpPWpGaD
Palonosetron—CYP1A2—liver—alcohol dependence	0.000365	0.0216	CbGeAlD
Palonosetron—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000365	0.00251	CbGpPWpGaD
Palonosetron—Dizziness—Citalopram—alcohol dependence	0.000362	0.00114	CcSEcCtD
Palonosetron—CYP3A4—digestive system—alcohol dependence	0.000355	0.021	CbGeAlD
Palonosetron—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.00035	0.00241	CbGpPWpGaD
Palonosetron—CYP2D6—digestive system—alcohol dependence	0.000349	0.0207	CbGeAlD
Palonosetron—Vomiting—Citalopram—alcohol dependence	0.000348	0.0011	CcSEcCtD
Palonosetron—Rash—Citalopram—alcohol dependence	0.000345	0.00109	CcSEcCtD
Palonosetron—Dermatitis—Citalopram—alcohol dependence	0.000344	0.00109	CcSEcCtD
Palonosetron—Headache—Citalopram—alcohol dependence	0.000343	0.00108	CcSEcCtD
Palonosetron—HTR3A—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.00034	0.00234	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00034	0.00233	CbGpPWpGaD
Palonosetron—CYP3A4—blood—alcohol dependence	0.000338	0.02	CbGeAlD
Palonosetron—CYP2D6—blood—alcohol dependence	0.000333	0.0197	CbGeAlD
Palonosetron—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000332	0.00228	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00033	0.00227	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000328	0.00225	CbGpPWpGaD
Palonosetron—Nausea—Citalopram—alcohol dependence	0.000325	0.00103	CcSEcCtD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000323	0.00222	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.00032	0.0022	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000319	0.00219	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.000313	0.00215	CbGpPWpGaD
Palonosetron—CYP3A4—endocrine gland—alcohol dependence	0.000293	0.0173	CbGeAlD
Palonosetron—CYP2D6—endocrine gland—alcohol dependence	0.000289	0.0171	CbGeAlD
Palonosetron—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000283	0.00194	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000282	0.00194	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000281	0.00193	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000279	0.00192	CbGpPWpGaD
Palonosetron—CYP2D6—testis—alcohol dependence	0.000275	0.0163	CbGeAlD
Palonosetron—CYP3A4—nervous system—alcohol dependence	0.000275	0.0162	CbGeAlD
Palonosetron—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.00027	0.00186	CbGpPWpGaD
Palonosetron—CYP2D6—nervous system—alcohol dependence	0.00027	0.016	CbGeAlD
Palonosetron—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.000266	0.00183	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000265	0.00182	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000265	0.00182	CbGpPWpGaD
Palonosetron—CYP3A4—liver—alcohol dependence	0.000265	0.0156	CbGeAlD
Palonosetron—CYP3A4—central nervous system—alcohol dependence	0.000264	0.0156	CbGeAlD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000262	0.0018	CbGpPWpGaD
Palonosetron—CYP2D6—liver—alcohol dependence	0.00026	0.0154	CbGeAlD
Palonosetron—CYP2D6—central nervous system—alcohol dependence	0.00026	0.0154	CbGeAlD
Palonosetron—CYP2D6—cerebellum—alcohol dependence	0.000254	0.015	CbGeAlD
Palonosetron—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000247	0.0017	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.000226	0.00155	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000224	0.00154	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000216	0.00148	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000215	0.00147	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000213	0.00146	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.00021	0.00144	CbGpPWpGaD
Palonosetron—CYP2D6—brain—alcohol dependence	0.000207	0.0122	CbGeAlD
Palonosetron—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000205	0.00141	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—GGT1—alcohol dependence	0.000196	0.00134	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000184	0.00126	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000184	0.00126	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000182	0.00125	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.00018	0.00124	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000178	0.00122	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—MAOA—alcohol dependence	0.000175	0.0012	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000174	0.0012	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000173	0.00119	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GGT1—alcohol dependence	0.000166	0.00114	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—MAOA—alcohol dependence	0.000148	0.00102	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.00014	0.000964	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000139	0.000956	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000137	0.000943	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000128	0.000878	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADH6—alcohol dependence	0.000123	0.000845	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000115	0.000787	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—POMC—alcohol dependence	0.000114	0.000783	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADH6—alcohol dependence	0.000104	0.000716	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADH1A—alcohol dependence	0.000102	0.0007	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—POMC—alcohol dependence	9.66e-05	0.000664	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADH4—alcohol dependence	8.67e-05	0.000596	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADH1A—alcohol dependence	8.64e-05	0.000593	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADH6—alcohol dependence	8.05e-05	0.000553	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—POMC—alcohol dependence	7.46e-05	0.000512	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADH7—alcohol dependence	7.37e-05	0.000506	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADH4—alcohol dependence	7.35e-05	0.000505	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GGT2—alcohol dependence	7.07e-05	0.000486	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADH1A—alcohol dependence	6.67e-05	0.000458	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADH1B—alcohol dependence	6.47e-05	0.000444	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.36e-05	0.000437	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADH7—alcohol dependence	6.25e-05	0.000429	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GGT2—alcohol dependence	5.99e-05	0.000411	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADH4—alcohol dependence	5.67e-05	0.000389	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADH1B—alcohol dependence	5.48e-05	0.000376	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MAOB—alcohol dependence	5.36e-05	0.000368	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADH7—alcohol dependence	4.82e-05	0.000331	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GGT2—alcohol dependence	4.62e-05	0.000317	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALDH2—alcohol dependence	4.56e-05	0.000313	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MAOB—alcohol dependence	4.54e-05	0.000312	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.23e-05	0.00029	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GOT2—alcohol dependence	3.87e-05	0.000266	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALDH2—alcohol dependence	3.86e-05	0.000265	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.71e-05	0.000255	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP2E1—alcohol dependence	3.64e-05	0.00025	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MAOB—alcohol dependence	3.5e-05	0.000241	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GGT1—alcohol dependence	3.34e-05	0.00023	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GOT1—alcohol dependence	3.34e-05	0.00023	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GOT2—alcohol dependence	3.28e-05	0.000225	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2E1—alcohol dependence	3.09e-05	0.000212	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MAOA—alcohol dependence	3e-05	0.000206	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.98e-05	0.000205	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GGT1—alcohol dependence	2.83e-05	0.000195	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GOT1—alcohol dependence	2.83e-05	0.000195	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MAOA—alcohol dependence	2.54e-05	0.000174	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GOT2—alcohol dependence	2.53e-05	0.000174	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.46e-05	0.000169	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.38e-05	0.000164	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GGT1—alcohol dependence	2.19e-05	0.00015	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GOT1—alcohol dependence	2.19e-05	0.00015	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MAOA—alcohol dependence	1.96e-05	0.000135	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—POMC—alcohol dependence	1.95e-05	0.000134	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—POMC—alcohol dependence	1.65e-05	0.000114	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—EP300—alcohol dependence	1.29e-05	8.89e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—POMC—alcohol dependence	1.28e-05	8.76e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—EP300—alcohol dependence	1.1e-05	7.53e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—EP300—alcohol dependence	8.46e-06	5.81e-05	CbGpPWpGaD
